Migraine Experts: Head-to-Head Drug Comparisons Better
Placebo-controlled trials are insufficient for decisions that affect medication availability in EU member states.
Stay updated with breaking news from Double Blind Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Placebo-controlled trials are insufficient for decisions that affect medication availability in EU member states.
Famed microbiome researcher Dr Martin J. Blaser shares what he sees as the most promising applications, and the rigorous clinical trials needed to realize them.
Findings from a large US cohort study show comparable accuracy, but better discrimination of patients across disease stages.
Experts urge rigorous research due to safety concerns and uncertainties and prefer naloxone as the preferred first-line agent.
A significant number of patients with moderate to severe atopic dermatitis (AD) failed to achieve adequate disease control with systemic therapies over 12 months, indicating a substantial degree of "therapeutic inertia."